Survival rate of early stage endometrioid adenocarcinoma of endometrium treated at Srinagarind Hospital
- PMID: 24716960
- DOI: 10.7314/apjcp.2014.15.5.2217
Survival rate of early stage endometrioid adenocarcinoma of endometrium treated at Srinagarind Hospital
Abstract
Purpose: To evaluate the survival outcome of early stage endometrioid adenocarcinoma of the endometrium with risk factors for locoregional recurrence treated with combined pelvic external beam radiotherapy (EBRT) and vaginal brachytherapy (VBT) after comprehensive surgery.
Materials and methods: Post-operative radiotherapy by pelvic EBRT and VBT for early stage endometrioid endometrial carcinoma resulted in excellent pelvic control with acceptable complications. This study showed no significant relationships between age, stage, histologic grade and LVSI and overall survival rate.
Results: The 5-year overall survival rate (OS) of early stage endometrioid type of endometrial carcinoma was 85.7%. Acute toxicity occurred in 38.1% of the patients, all of whom were grade 1 or 2. Total late toxicity developed in 42.9% of study group, in which 36.99% of them were grade 1-2 and 4.76% were grade 3-4.
Conclusions: Post-operative radiotherapy by pelvic EBRT and VBT is acceptable for early stage endometrioid endometrial carcinoma, independent of age, stage, histologic grade and LVSI.
Similar articles
-
Treatment optimization of pelvic external beam radiation and/or vaginal brachytherapy for patients with stage I to II high-risk Endometrioid adenocarcinoma: a retrospective multi-institutional analysis.BMC Cancer. 2021 Jul 4;21(1):774. doi: 10.1186/s12885-021-08524-x. BMC Cancer. 2021. PMID: 34217240 Free PMC article.
-
Overview of adjuvant radiotherapy on survival, failure pattern and toxicity in stage I to II endometrial carcinoma: a long-term multi-institutional analysis in China.BMC Cancer. 2022 Mar 14;22(1):266. doi: 10.1186/s12885-022-09343-4. BMC Cancer. 2022. PMID: 35287626 Free PMC article.
-
External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma--a prospective randomized study.Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):1249-55. doi: 10.1016/j.ijrobp.2011.04.014. Epub 2011 Jun 14. Int J Radiat Oncol Biol Phys. 2012. PMID: 21676554 Clinical Trial.
-
Isolated vaginal recurrences in endometrial carcinoma: treatment results using high-dose-rate intracavitary brachytherapy and external beam radiotherapy.Gynecol Oncol. 1997 Aug;66(2):300-7. doi: 10.1006/gyno.1997.4752. Gynecol Oncol. 1997. PMID: 9264580 Review.
-
Vaginal brachytherapy alone is sufficient adjuvant treatment of surgical stage I endometrial cancer.Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1379-84. doi: 10.1016/j.ijrobp.2005.01.026. Int J Radiat Oncol Biol Phys. 2005. PMID: 16029796 Review.
Cited by
-
Sentinel Lymph Nodes in Endometrial Cancer Update 2018.Gynecol Minim Invasive Ther. 2019 Aug 29;8(3):94-100. doi: 10.4103/GMIT.GMIT_130_18. eCollection 2019 Jul-Sep. Gynecol Minim Invasive Ther. 2019. PMID: 31544018 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources